E-mail: bd@sidmexinovia.com
Telefone: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Erypeg 50 mcg PFS
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$55.43 $34.57
Erypeg 50 mcg is a specialized injectable medication classified as an erythropoiesis-stimulating agent (ESA), designed to combat anemia, particularly in patients suffering from chronic kidney disease or those undergoing chemotherapy....
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Erythropoietin 50 mcg(Pegylated)
Active Pharmaceutical Ingredient
Erypeg 50 mcg PFS
US$ 55,43
US$ 34,57
Erypeg 50 mcg is a specialized injectable medication classified as an erythropoiesis-stimulating agent (ESA), designed to combat anemia, particularly in patients suffering from chronic kidney disease or those undergoing chemotherapy. This pegylated erythropoietin formulation effectively stimulates the bone marrow to enhance red blood cell production, thereby improving oxygen delivery throughout the body. Patients using Erypeg should be aware of potential side effects, including hypertension and an increased risk of thromboembolic events, necessitating careful monitoring by healthcare professionals. It is essential to adhere to prescribed dosages to avoid complications associated with overuse. As a vital option in managing anemia, Erypeg plays a crucial role in improving the quality of life for individuals facing these health challenges. Always consult your healthcare provider before starting treatment to ensure it is appropriate for your condition. By understanding the benefits and precautions associated with Erypeg, patients can make informed decisions about their anemia management.
Active Pharmaceutical Ingredient
Usos
• Erypeg 50 mcg pfs is primarily indicated for the treatment of symptomatic anemia associated with chronic renal failure (CRF). This condition can significantly impact patients' quality of life, leading to fatigue and weakness. By stimulating red blood cell production, Erypeg 50 mcg pfs helps to alleviate these symptoms. It is effective for both adult and pediatric populations, ensuring comprehensive care.
• Patients undergoing dialysis often experience anemia due to reduced erythropoietin production. Erypeg 50 mcg pfs serves as a crucial therapeutic option for these individuals, promoting the generation of red blood cells. This treatment can enhance their energy levels and overall well-being. The administration of Erypeg 50 mcg pfs is tailored to meet the specific needs of dialysis patients.
• In addition to patients on dialysis, Erypeg 50 mcg pfs is also beneficial for those with CRF who are not receiving dialysis. This medication helps manage anemia in various stages of chronic renal failure, providing relief from symptoms. By improving hemoglobin levels, Erypeg 50 mcg pfs contributes to better physical performance and daily functioning. It is an essential part of the anemia management strategy in renal care.
• The use of Erypeg 50 mcg pfs extends to both adult and pediatric patients, making it a versatile option in treating anemia related to chronic renal failure. Its formulation allows for effective administration across different age groups, addressing the unique needs of each patient. By enhancing red blood cell production, Erypeg 50 mcg pfs aids in reducing the complications associated with anemia. This makes it a valuable tool in comprehensive patient management.
Benefícios
Treatment of Anemia due to chronic kidney disease: Erythropoietin Pegylated Injection 50 mcg is a man-made protein that helps your bone marrow make more red blood cells. It is used to treat anaemia caused by kidney disease in adults and children on dialysis. Anaemia is a condition in which your body does not have enough red blood cells to carry oxygen around your body. This medicine helps to reduce the weakness and tiredness you may feel due to anaemia. It is usually given by a doctor after dialysis treatment.
Treatment of anaemia caused by cancer chemotherapy: Anemia is a condition in which your body does not have enough red blood cells to carry oxygen around your body. Anti-anemia Drug Erypeg is a man-made protein that stimulates the bone marrow (soft tissue inside the bones) to produce more red blood cells. The natural human form of this protein may be reduced when you have chemotherapy to treat some types of cancer. An injection of the medicine may reduce the need for a blood transfusion. You may also be given an iron supplement to help make sure the treatment is more effective.
Efeitos colaterais
Like all medications, Anti-anemia Drug Erypeg can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor on the occasion that they persist or if you’re worried about them.
Efeitos colaterais mais comuns
• Feeling Sick
• Diarrhoea
• Headaches
• Vomiting
• Rash
• Hives
• Itching
• Tiredness
• Lack of energy
• Wheezing
• Skin blisters or peeling skin
• Dizziness
• Faining
• Swollen hands or feet
Efeitos colaterais comuns
• Chest Pain
• Difficulty breathing
• Swelling on the throat, lips, face, eyes or lips
• Breathlessness
• Eyesight problems
• Numbness or weakness in one side of your body
• Rash
• Hives
• Itching
• Tiredness
• Lack of energy
• Wheezing
• Skin blisters or peeling skin
• Dizziness
• Faining
• Swollen hands or feet
Como usar
Anti-anemia Drug Erypeg is available in liquid form and is administered subcutaneously by a slow injection. This Erythropoietin Pegylated Injection 50 mcg is usually given in the abdomen or thigh. The dosage and frequency of injections for Erypeg 50 mcg will be determined by your healthcare provider. If you experience any serious side effects, it is important to tell your healthcare provider or doctor.
Conselhos de segurança
• Alcohol: It is generally not recommended to drink alcohol while taking Anti-anemia Drug Erypeg. It may also increase the chance of liver damage. it is far excellent to keep away from alcohol or restrict your alcohol intake while taking any medication.
• Kidney: Erypeg 50 mcg is safe to use in patients with kidney disease. No dose adjustment of Erypeg 50 mcg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Erypeg 50 mcg. Erypeg 50 mcg may pass into breast milk and harm the infant. If you are breastfeeding and taking Erythropoietin Pegylated Injection 50 mcg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your health practitioner can be capin a position that will help you make the nice choice for you and your baby's health.
• Liver: Anti-anemia Drug Erypeg should be used with caution in patients with liver disease. Sufferers with liver disease must monitor their liver closely even while taking Erypeg 50 mcg and report any unusual symptoms or changes in liver function to their doctor. The dose of Erythropoietin Pegylated Injection 50 mcg may need to be adjusted in patients with liver disease.
• Pregnancy: Animal studies suggest that Anti-anemia Drug Erypeg may harm the developing foetus, so it may not be safe to use Erypeg 50 mcg during pregnancy. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erypeg 50 mcg while pregnant. Your doctor will be able to help you make the best decision for you and the health of your baby.
• Driving: This Erypeg 50 mcg may cause dizziness, drowsiness, and problems with concentration and coordination, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's orders and take important precautions, including not driving or operating heavy machinery, if you are experiencing the side effects of this Anti-anemia Drug Erypeg.
Isenção de responsabilidade
A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.
Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.
Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.
Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.